TTP according to BCL2 genetic alterations with or without IPI risk groups in each COO subtype. (A-D) TTP according to presence of BCL2^GA in ABC-DLBCL (A), BCL2^TR in GCB-DLBCL (B), BCL2^GA with IPI in ABC-DLBCL (C), and BCL2^TR with IPI in GCB-DLBCL (D).